SECOND AMENDMENT TO PLASMA PURCHASE AGREEMENT NORMAL SOURCE PLASMA PURCHASE FROM BPC TO ADMAPlasma Purchase Agreement • May 12th, 2021 • Adma Biologics, Inc. • Biological products, (no disgnostic substances)
This Second Amendment to the Plasma Purchase Agreement (this “Amendment #2”) by and between Grifols Worldwide Operations Limited, a corporation having a place of business at Grange Castle Business Park, Grange Castle, Clondalkin, Dublin 22, Ireland (“GWWO”), as the successor-in-interest to BPC Plasma, Inc., formerly, Biotest Pharmaceuticals Corporation (“BPC”), and ADMA BioManufacturing, LLC., a Delaware limited liability corporation having a place of business at 465 Route 17 South, Ramsey, New Jersey 07446 (“ADMA”), is effective as of May 12, 2021 execution (the “Effective Date”).
